Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Valvular Heart Disease

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 121 articles:
HTML format



Single Articles


    June 2025
  1. LIM HJ, Kim K, Gwak SY, Lee HJ, et al
    Early predictors of aortic valve surgery in patients with significant bicuspid aortic regurgitation without initial surgical indication.
    Heart. 2025 Jun 20:heartjnl-2025-325892. doi: 10.1136/heartjnl-2025-325892.
    PubMed     Abstract available


  2. FALK V
    60: 'the magic number of greatness' in minimally invasive mitral valve repair?
    Heart. 2025 Jun 20:heartjnl-2025-326326. doi: 10.1136/heartjnl-2025-326326.
    PubMed    


  3. KASSAR M, Gercek M, Rudolph V
    Shadows and light in transcatheter mitral valve treatment: recent evidence and implications for clinical practice.
    Heart. 2025 Jun 15:heartjnl-2024-325621. doi: 10.1136/heartjnl-2024-325621.
    PubMed    


  4. HEUTS S, Kawczynski MJ, Maesen B, Vriesendorp PA, et al
    When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantation.
    Heart. 2025 Jun 10:heartjnl-2025-326208. doi: 10.1136/heartjnl-2025-326208.
    PubMed     Abstract available


    May 2025
  5. SUN Y, Wang C, Li J, Luo S, et al
    Outcomes of transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis with severe calcification.
    Heart. 2025 May 10:heartjnl-2024-324697. doi: 10.1136/heartjnl-2024-324697.
    PubMed     Abstract available


  6. NAKASE M, Draxler DF, Tomii D, Heg D, et al
    Incidence, predictors and clinical impact of upper gastrointestinal bleeding after transcatheter aortic valve replacement.
    Heart. 2025 May 10:heartjnl-2024-325359. doi: 10.1136/heartjnl-2024-325359.
    PubMed     Abstract available


  7. HEUTS S, Hjij W, Kawczynski MJ, Olsthoorn JR, et al
    Defining centres of expertise for minimally invasive mitral valve surgery: a systematic review and volume-outcome meta-analysis.
    Heart. 2025 May 10:heartjnl-2024-325048. doi: 10.1136/heartjnl-2024-325048.
    PubMed     Abstract available


    April 2025
  8. WANG C, Hamid N, Bapat V, Cavalcante JL, et al
    Incidence, predictors and outcomes of tricuspid regurgitation progression after left-sided valvular intervention.
    Heart. 2025 Apr 30:heartjnl-2024-325194. doi: 10.1136/heartjnl-2024-325194.
    PubMed     Abstract available


  9. MCCANN GP, Newby DE, Hillis GS
    TAVI for asymptomatic aortic stenosis? More compelling outcome data are needed.
    Heart. 2025 Apr 15:heartjnl-2025-325767. doi: 10.1136/heartjnl-2025-325767.
    PubMed    


    March 2025
  10. CELMETA B, Miceli A
    Bacteraemia and infective endocarditis after transcatheter aortic valve replacement: prevention is the key.
    Heart. 2025 Mar 23:heartjnl-2024-325410. doi: 10.1136/heartjnl-2024-325410.
    PubMed    


  11. GEERS J, Manral N, Razipour A, Park C, et al
    Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial.
    Heart. 2025 Mar 6:heartjnl-2024-324925. doi: 10.1136/heartjnl-2024-324925.
    PubMed     Abstract available


  12. PANG L, Xia Y, Tang M, Ma M, et al
    Prevalence, spectrum and aetiology of valvular heart disease based on community echocardiographic screening transition from different altitudes in Yunnan, China.
    Heart. 2025 Mar 3:heartjnl-2024-325221. doi: 10.1136/heartjnl-2024-325221.
    PubMed     Abstract available


    February 2025
  13. LEE HJ, Gwak SY, Kim K, Cho I, et al
    Factors associated with high-intensity physical activity and sudden cardiac death in hypertrophic cardiomyopathy.
    Heart. 2025;111:253-261.
    PubMed     Abstract available


  14. LIND V, Lundman P, Friberg L, Talback M, et al
    Dysglycaemia and incident aortic stenosis: a cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-325150. doi: 10.1136/heartjnl-2024-325150.
    PubMed     Abstract available


  15. TREWAREE S, Shantsila A, Lip GYH
    Pulse pressure and aortic valve peak velocity as new predictors of heart failure in patients post-myocardial infarction.
    Heart. 2025 Feb 6:heartjnl-2024-325513. doi: 10.1136/heartjnl-2024-325513.
    PubMed    


  16. OKADA T, Kagiyama N, Kaneko T, Amano M, et al
    Echocardiographic cardiac damage classification and clinical outcomes in atrial functional mitral regurgitation.
    Heart. 2025 Feb 6:heartjnl-2024-325240. doi: 10.1136/heartjnl-2024-325240.
    PubMed     Abstract available


  17. WU Y, Zhao J, Chen C, Huang J, et al
    Pulse pressure and aortic valve peak velocity and incident heart failure after myocardial infarction: a cohort study.
    Heart. 2025 Feb 6:heartjnl-2024-324517. doi: 10.1136/heartjnl-2024-324517.
    PubMed     Abstract available


    January 2025
  18. CHRISTENSEN EB, Vissing CR, Silajdzija E, Mills HL, et al
    Long-term incidence of implantable cardioverter-defibrillator therapy in patients with hypertrophic cardiomyopathy: analysis of appropriate and inappropriate interventions.
    Heart. 2025 Jan 19:heartjnl-2024-325020. doi: 10.1136/heartjnl-2024-325020.
    PubMed     Abstract available


  19. CRAIG N, Dweck MR
    Sociodemographic treatment trends for aortic stenosis since the adoption of transcatheter aortic valve intervention.
    Heart. 2025 Jan 16:heartjnl-2024-325328. doi: 10.1136/heartjnl-2024-325328.
    PubMed    


  20. DONAL E, Gegout L, Bourg C
    Reassessing the role of tricuspid valve surgery in the modern era.
    Heart. 2025 Jan 16:heartjnl-2024-325476. doi: 10.1136/heartjnl-2024-325476.
    PubMed    


    December 2024
  21. LIU R, Fu Z, Yan Y, Xie M, et al
    New wearable cardiac acoustic monitoring technology for evaluation of subclinical leaflet thrombosis after transcatheter aortic valve replacement.
    Heart. 2024 Dec 25:heartjnl-2024-324698. doi: 10.1136/heartjnl-2024-324698.
    PubMed     Abstract available


  22. DOEDENS A, Skarp S, Holmstrom L, Pakanen L, et al
    Genetic variants associated with cardiac hypertrophy-related sudden cardiac death and cardiovascular outcomes in a Finnish population.
    Heart. 2024;111:55-61.
    PubMed     Abstract available


  23. PLAYFORD D, Stewart S, Harris SA, Scalia G, et al
    Mortality associated with moderate and severe mitral regurgitation in 608 570 men and women undergoing echocardiography.
    Heart. 2024 Dec 20:heartjnl-2024-324790. doi: 10.1136/heartjnl-2024-324790.
    PubMed     Abstract available


  24. HADJI-TURDEGHAL K, Petersen JK, Graversen PL, Butt JH, et al
    Bacteraemia after transcatheter aortic valve implantation: a nationwide cohort study.
    Heart. 2024 Dec 20:heartjnl-2024-324803. doi: 10.1136/heartjnl-2024-324803.
    PubMed     Abstract available


  25. GWAK SY, Kim K, Lee HJ, Cho I, et al
    Outcomes of tricuspid valve surgery in patients with significant tricuspid regurgitation and low to intermediate risk.
    Heart. 2024 Dec 17:heartjnl-2024-324891. doi: 10.1136/heartjnl-2024-324891.
    PubMed     Abstract available


  26. YONES E, Gunn J, Iqbal J, Morris PD, et al
    Functional assessment of coronary artery disease in patients with severe aortic stenosis: a review.
    Heart. 2024 Dec 12:heartjnl-2024-324802. doi: 10.1136/heartjnl-2024-324802.
    PubMed     Abstract available


  27. DIGREGORIO H, Mansoorshahi S, Carlisle SG, Tovar Pensa C, et al
    Contribution of rare chromosome 22q11.2 copy number variants to non-syndromic bicuspid aortic valve.
    Heart. 2024 Dec 10:heartjnl-2024-324669. doi: 10.1136/heartjnl-2024-324669.
    PubMed     Abstract available


    November 2024
  28. SINGH A, Chalmers F, Aslam S, Bolton T, et al
    Surgical and transcatheter aortic valve interventions for aortic stenosis in England: sociodemographic variations in treatment trends and outcome over 20 years.
    Heart. 2024 Nov 27:heartjnl-2024-324918. doi: 10.1136/heartjnl-2024-324918.
    PubMed     Abstract available


  29. DONAL E, Rouleau L
    Optimising management of moderate secondary mitral regurgitation: insights into pharmacological and interventional approaches.
    Heart. 2024 Nov 7:heartjnl-2024-325097. doi: 10.1136/heartjnl-2024-325097.
    PubMed    


  30. BJORN R, Strom JB, Lloyd G, Bhattacharyya S, et al
    Asymptomatic severe degenerative mitral regurgitation.
    Heart. 2024 Nov 7:heartjnl-2024-324739. doi: 10.1136/heartjnl-2024-324739.
    PubMed     Abstract available


    October 2024
  31. SARRAZYN C, Fortuni F, Laenens D, Chua AP, et al
    Clinical and echocardiographic parameters associated with outcomes in patients with moderate secondary mitral regurgitation.
    Heart. 2024 Oct 4:heartjnl-2024-324526. doi: 10.1136/heartjnl-2024-324526.
    PubMed     Abstract available


    September 2024
  32. LAI FY, Gibbison B, O'Cathain A, Akowuah E, et al
    Inequalities in access to and outcomes of cardiac surgery in England: retrospective analysis of Hospital Episode Statistics (2010-2019).
    Heart. 2024 Sep 3:heartjnl-2024-324292. doi: 10.1136/heartjnl-2024-324292.
    PubMed     Abstract available


    August 2024
  33. GALLI E, Le Ven F, Coisne A, Sportouch C, et al
    Randomised study for the Optimal Treatment of symptomatic patients with low-gradient severe Aortic valve Stenosis and preserved left ventricular ejection fraction (ROTAS trial).
    Heart. 2024 Aug 28:heartjnl-2024-324224. doi: 10.1136/heartjnl-2024-324224.
    PubMed     Abstract available


  34. JAHANGIRI M, Prendergast B
    Management of bicuspid aortic valve disease in the transcatheter aortic valve implantation era.
    Heart. 2024 Aug 7:heartjnl-2024-324054. doi: 10.1136/heartjnl-2024-324054.
    PubMed     Abstract available


    June 2024
  35. RHEE TM, Kim HK
    Integrating machine learning approach to identify sleep-disordered breathing in hypertrophic cardiomyopathy.
    Heart. 2024;110:931-932.
    PubMed    


  36. AKITA K, Kageyama S, Suzuki S, Ohno K, et al
    Machine learning-based detection of sleep-disordered breathing in hypertrophic cardiomyopathy.
    Heart. 2024;110:954-962.
    PubMed     Abstract available


  37. KLADOU E, Kochiadakis G, Hamilos M
    Unexpected finding on imaging: an aortic valve mass.
    Heart. 2024;110:939-970.
    PubMed    


    April 2024
  38. KUMAR M, Pettinato A, Ladha F, Earp JE, et al
    Sarcopenia and aortic valve disease.
    Heart. 2024 Apr 22:heartjnl-2024-324029. doi: 10.1136/heartjnl-2024-324029.
    PubMed     Abstract available


    March 2024
  39. BIEROWSKI MJ, Warner ED, Edirisuriya CD
    Mitral valve dysfunction in a woman with newly diagnosed acute promyelocytic leukemia.
    Heart. 2024;110:507-540.
    PubMed    


    February 2024
  40. UBBEN T, Frerker C, Fujita B, Rosenkranz S, et al
    Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair.
    Heart. 2024 Feb 22:heartjnl-2023-323473. doi: 10.1136/heartjnl-2023-323473.
    PubMed     Abstract available


  41. TA S, Li J, Hsi DH, Hu R, et al
    Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up.
    Heart. 2024 Feb 22:heartjnl-2023-323606. doi: 10.1136/heartjnl-2023-323606.
    PubMed     Abstract available


    January 2024
  42. WACHTELL K
    Understanding the driving mechanisms of bioprosthetic valve degeneration.
    Heart. 2024;110:223-224.
    PubMed    


  43. GUAL-CAPLLONCH F, Pericas P
    Correspondence on 'Echocardiographic estimation of pulmonary pressure in patients with severe tricuspid regurgitation' by Lemarchand et al.
    Heart. 2024 Jan 18:heartjnl-2023-323697. doi: 10.1136/heartjnl-2023-323697.
    PubMed    


    December 2023
  44. PATEL KP, McKenna M, Thornton GD, Vandermolen S, et al
    Predictors of outcome in patients with moderate mixed aortic valve disease.
    Heart. 2023 Dec 26:heartjnl-2023-323321. doi: 10.1136/heartjnl-2023-323321.
    PubMed     Abstract available


  45. DELWARDE C, Toquet C, Boureau AS, Le Ruz R, et al
    Filamin A heart valve disease as a genetic cause of inherited bicuspid and tricuspid aortic valve disease.
    Heart. 2023 Dec 26:heartjnl-2023-323491. doi: 10.1136/heartjnl-2023-323491.
    PubMed     Abstract available


  46. PAVON AG, Guglielmo M
    Carcinoid heart disease: another step into the knowledge of a rare disease.
    Heart. 2023;110:79-80.
    PubMed    


  47. MONDAL S, Kumar SS, Kesavan V
    Case of presyncope with mitral regurgitation.
    Heart. 2023;110:18-74.
    PubMed    


  48. SATURI G, De Frutos F, Sguazzotti M, Gonzalez-Lopez E, et al
    Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis.
    Heart. 2023;110:40-48.
    PubMed     Abstract available


  49. JANDER N, Minners J
    Towards a gender-specific and morphology-specific assessment of aortic valve stenosis severity.
    Heart. 2023 Dec 12:heartjnl-2023-323499. doi: 10.1136/heartjnl-2023-323499.
    PubMed    


  50. SCARSINI R, Portolan L, Della Mora F, Fabroni M, et al
    Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation.
    Heart. 2023 Dec 1:heartjnl-2023-323461. doi: 10.1136/heartjnl-2023-323461.
    PubMed     Abstract available


    November 2023
  51. HAZEBROEK MR, Verdonschot JAJ
    One step closer to the new frontiers of healthcare for cardiomyopathy patients.
    Heart. 2023;109:1808-1810.
    PubMed    


  52. ANDERSON RH, Spicer DE, Sanchez-Quintana D, Macias Y, et al
    Relationship between the aortic root and the atrioventricular conduction axis.
    Heart. 2023;109:1811-1818.
    PubMed     Abstract available


  53. ANDERSON RH, Westaby J, Sheppard MN, Cook AC, et al
    Mitral annular disjunction: a ubiquitous finding with or without mitral valvar prolapse.
    Heart. 2023 Nov 24:heartjnl-2023-323501. doi: 10.1136/heartjnl-2023-323501.
    PubMed    


  54. HEUTS S, Gabrio A, Veenstra L, Maesen B, et al
    Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis.
    Heart. 2023 Nov 23:heartjnl-2023-323359. doi: 10.1136/heartjnl-2023-323359.
    PubMed     Abstract available


  55. LAWIN D, Stellbrink C, Stellbrink E, Buck B, et al
    Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy.
    Heart. 2023;109:1778-1784.
    PubMed     Abstract available


  56. BAROUTIDOU A, Arvanitaki A, Farmakis IT, Patsiou V, et al
    Transcatheter closure of atrial septal defect in the elderly: a systematic review and meta-analysis.
    Heart. 2023;109:1741-1750.
    PubMed     Abstract available


  57. KRAWCZYK-OZOG A, Batko J, Zdzierak B, Dziewierz A, et al
    Morphology of the mural and commissural atrioventricular junction of the mitral valve.
    Heart. 2023 Nov 7:heartjnl-2023-322965. doi: 10.1136/heartjnl-2023-322965.
    PubMed     Abstract available


  58. TOMASELLI M, Badano LP, Muraru D
    Right atrial function, a mostly ignored but very valuable parameter in patients with secondary tricuspid regurgitation.
    Heart. 2023 Nov 6:heartjnl-2023-323426. doi: 10.1136/heartjnl-2023-323426.
    PubMed    


  59. BOTEZATU SB, Yu X, Meah MN, Williams MC, et al
    Aortic valve perivascular adipose tissue computed tomography attenuation in patients with aortic stenosis.
    Heart. 2023 Nov 2:heartjnl-2023-323217. doi: 10.1136/heartjnl-2023-323217.
    PubMed     Abstract available


    October 2023
  60. GALLOO X, Fortuni F, Meucci MC, Butcher SC, et al
    Association of right atrial strain and long-term outcome in severe secondary tricuspid regurgitation.
    Heart. 2023 Oct 30:heartjnl-2023-323084. doi: 10.1136/heartjnl-2023-323084.
    PubMed     Abstract available


  61. YE Z, Clavel MA, Foley TA, Pibarot P, et al
    Computed tomography calcium scoring in aortic stenosis: bicuspid versus tricuspid morphology.
    Heart. 2023 Oct 30:heartjnl-2023-323281. doi: 10.1136/heartjnl-2023-323281.
    PubMed     Abstract available


  62. CHA MJ, Lee SA, Cho MS, Nam GB, et al
    Reduction of moderate to severe tricuspid regurgitation after catheter ablation for atrial fibrillation.
    Heart. 2023 Oct 25:heartjnl-2023-323244. doi: 10.1136/heartjnl-2023-323244.
    PubMed     Abstract available


  63. LEMARCHAND L, Auffret V, Le Breton H, Bedossa M, et al
    Echocardiographic estimation of pulmonary pressure in patients with severe tricuspid regurgitation.
    Heart. 2023 Oct 12:heartjnl-2023-322893. doi: 10.1136/heartjnl-2023-322893.
    PubMed     Abstract available


  64. OTTO CM, Bartkowiak J, Hahn RT
    Right atrial pressure, not Doppler jet velocity, is the problem in estimating pulmonary pressure when tricuspid regurgitation is severe.
    Heart. 2023 Oct 12:heartjnl-2023-323230. doi: 10.1136/heartjnl-2023-323230.
    PubMed    


  65. VEERARAGHAVAN S, Kidambi BR
    Sudden-onset breathlessness in a middle-aged man.
    Heart. 2023;109:1601-1650.
    PubMed    


  66. DEMAL TJ, Conradi L
    Management of valve dysfunction in patients with mitral annular calcification.
    Heart. 2023;109:1639-1646.
    PubMed    


    September 2023
  67. OTTO CM
    Heartbeat: a trend over the past 20 years towards decreased aortic stenosis mortality in patients aged 80 years or older.
    Heart. 2023;109:1419-1421.
    PubMed    


  68. MICHELENA HI, Anand V, Enriquez-Sarano M, Pellikka PA, et al
    Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Ratwatte et al.
    Heart. 2023 Sep 1:heartjnl-2023-323347. doi: 10.1136/heartjnl-2023-323347.
    PubMed    


  69. RATWATTE S, Celermajer DS
    Response to: Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Michelena et al.
    Heart. 2023 Sep 1:heartjnl-2023-323348. doi: 10.1136/heartjnl-2023-323348.
    PubMed    


    August 2023
  70. FARINA JM, Chao CJ, Pereyra M, Roarke M, et al
    Role of lipoprotein(a) concentrations in bioprosthetic aortic valve degeneration.
    Heart. 2023 Aug 29:heartjnl-2023-322987. doi: 10.1136/heartjnl-2023-322987.
    PubMed     Abstract available


  71. BARNES C, Sharma H, Gamble J, Dawkins S, et al
    Management of secondary mitral regurgitation: from drugs to devices.
    Heart. 2023 Aug 22:heartjnl-2022-322001. doi: 10.1136/heartjnl-2022-322001.
    PubMed     Abstract available


  72. JANG MH, Ahn JM, Kang DY, Kim KW, et al
    Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement.
    Heart. 2023 Aug 16:heartjnl-2023-322946. doi: 10.1136/heartjnl-2023-322946.
    PubMed     Abstract available


  73. XU Z, Gong C, Chen Y
    Patient in their 40s with unexplained myocardial hypertrophy.
    Heart. 2023;109:1280-1340.
    PubMed    


  74. OTTO CM
    Heartbeat: elevated pulmonary pressures in adults with aortic valve disease.
    Heart. 2023;109:1263-1265.
    PubMed    


  75. KUSUNOSE K, Ikemiyagi H
    Prognostic implications of pulmonary vascular resistance in transcatheter aortic valve implantation.
    Heart. 2023 Aug 8:heartjnl-2023-323094. doi: 10.1136/heartjnl-2023-323094.
    PubMed    


    July 2023
  76. LIEBENBERG J, Doubell A, Steyn J, Herbst P, et al
    Exploring the mechanisms responsible for reduced systolic function in high-gradient aortic stenosis.
    Heart. 2023 Jul 24:heartjnl-2023-322727. doi: 10.1136/heartjnl-2023-322727.
    PubMed     Abstract available


  77. MASSERA D, Bartz TM, Biggs ML, Sotoodehnia N, et al
    Traditional and novel risk factors for incident aortic stenosis in community-dwelling older adults.
    Heart. 2023 Jul 18:heartjnl-2023-322709. doi: 10.1136/heartjnl-2023-322709.
    PubMed     Abstract available


  78. MARTINSSON A, Torngren C, Nielsen SJ, Pan E, et al
    Renin-angiotensin system inhibition after surgical aortic valve replacement for aortic stenosis.
    Heart. 2023 Jul 17:heartjnl-2023-322922. doi: 10.1136/heartjnl-2023-322922.
    PubMed     Abstract available


  79. LUMISH HS, Liang LW, Hasegawa K, Maurer MS, et al
    Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics.
    Heart. 2023 Jul 14:heartjnl-2023-322644. doi: 10.1136/heartjnl-2023-322644.
    PubMed     Abstract available


  80. AFOKE J, Camacho E, Bagameri G
    Recurrent ventricular arrhythmia after aortic root replacement and mitral valve repair.
    Heart. 2023;109:1145-1192.
    PubMed    


  81. FARRANT J, Dodd S, Vaughan C, Reid A, et al
    Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.
    Heart. 2023;109:1175-1182.
    PubMed     Abstract available


  82. CARDAIOLI F, Nai Fovino L, Fabris T, Masiero G, et al
    Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation.
    Heart. 2023 Jul 6:heartjnl-2023-322881. doi: 10.1136/heartjnl-2023-322881.
    PubMed     Abstract available


  83. HOHMANN C, Pfister R, Frerker C, Beckmann A, et al
    Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation.
    Heart. 2023 Jul 5:heartjnl-2023-322548. doi: 10.1136/heartjnl-2023-322548.
    PubMed     Abstract available


    June 2023
  84. NGUYEN DD, Arnold SV
    Impact of frailty on disease-specific health status in cardiovascular disease.
    Heart. 2023;109:977-983.
    PubMed     Abstract available


  85. COURTNEY WA, Schultz CJ, Hillis GS
    Aortic valve calcification and outcomes in severe aortic stenosis.
    Heart. 2023 Jun 8:heartjnl-2023-322771. doi: 10.1136/heartjnl-2023-322771.
    PubMed    


  86. CHOI Y, Ahn JM, Yang DH, Koo HJ, et al
    Clinical outcomes after aortic valve replacement with severe stenosis of trileaflet aortic valve and low valve calcium score.
    Heart. 2023 Jun 8:heartjnl-2023-322435. doi: 10.1136/heartjnl-2023-322435.
    PubMed     Abstract available


  87. SAN ROMAN JA, Ybarra-Falcon C, Garcia-Gomez M, Ramos N, et al
    Recurrence of syncope after valve replacement in severe aortic stenosis.
    Heart. 2023 Jun 7:heartjnl-2023-322859. doi: 10.1136/heartjnl-2023-322859.
    PubMed     Abstract available


    May 2023
  88. PISLARU SV, Nkomo VT
    Subannular repair for secondary mitral regurgitation: a step towards peaceful conversations.
    Heart. 2023 May 31:heartjnl-2023-322609. doi: 10.1136/heartjnl-2023-322609.
    PubMed    


  89. NIENABER CA, Yuan X, Nienaber SA
    Aortic stenosis may not be fatal anymore in wealthy societies: but what about the rest of the world?
    Heart. 2023 May 26:heartjnl-2023-322737. doi: 10.1136/heartjnl-2023-322737.
    PubMed    


  90. SEVILLA T, Rojas G, Gonzalez-Bartol E, Candela J, et al
    Magnetic resonance analysis of ventricular volumes in bicuspid and trileaflet aortic regurgitation.
    Heart. 2023 May 25:heartjnl-2023-322519. doi: 10.1136/heartjnl-2023-322519.
    PubMed     Abstract available


  91. ANGUITA-GAMEZ M, Giraldo MA, Nombela-Franco L, Eixeres Esteve A, et al
    Validation of the TRI-SCORE in patients undergoing surgery for isolated tricuspid regurgitation.
    Heart. 2023 May 22:heartjnl-2022-322067. doi: 10.1136/heartjnl-2022-322067.
    PubMed     Abstract available


  92. HIBINO M, Pandey AK, Hibino H, Verma R, et al
    Mortality trends of aortic stenosis in high-income countries from 2000 to 2020.
    Heart. 2023 May 19:heartjnl-2023-322397. doi: 10.1136/heartjnl-2023-322397.
    PubMed     Abstract available


  93. OTTO CM
    Heartbeat: Choice of aortic valve intervention in younger adults.
    Heart. 2023;109:807-809.
    PubMed    


  94. SHAH BN
    National Institute for Health and Care Excellence (NICE) guidance on heart valve disease.
    Heart. 2023;109:817-822.
    PubMed     Abstract available


  95. VAN HOOF L, Lamberigts M, Noe D, El-Hamamsy I, et al
    Matched comparison between external aortic root support and valve-sparing root replacement.
    Heart. 2023;109:832-838.
    PubMed     Abstract available


  96. NUNES MCP, Barbosa JAA, Mocumbi A
    Refining morphological echocardiographic criteria to improve early detection of rheumatic heart disease.
    Heart. 2023 May 12:heartjnl-2022-322325. doi: 10.1136/heartjnl-2022-322325.
    PubMed    


  97. OH JK, Shen M, Guzzetti E, Tastet L, et al
    Effect of race on pressure recovery adjustment for prevention of aortic stenosis grading discordance.
    Heart. 2023 May 5:heartjnl-2023-322586. doi: 10.1136/heartjnl-2023-322586.
    PubMed     Abstract available


  98. LEEDY D, Elison DM, Farias F, Cheng R, et al
    Transcatheter aortic valve intervention in patients with cancer.
    Heart. 2023 May 5:heartjnl-2022-321396. doi: 10.1136/heartjnl-2022-321396.
    PubMed     Abstract available


  99. GALIAN-GAY L, Pijuan-Domenech A, Cantalapiedra-Romero J, Serrano B, et al
    Pregnancy-related aortic complications in women with bicuspid aortic valve.
    Heart. 2023 May 5:heartjnl-2022-322328. doi: 10.1136/heartjnl-2022-322328.
    PubMed     Abstract available


  100. SAN ROMAN JA
    Correspondence on "Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics" by Paolisso et al.
    Heart. 2023 May 3:heartjnl-2023-322844. doi: 10.1136/heartjnl-2023-322844.
    PubMed    


  101. VAN CAMP G
    Response to: Correspondence on "Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics" by Jose Alberto San Roman.
    Heart. 2023 May 3:heartjnl-2023-322845. doi: 10.1136/heartjnl-2023-322845.
    PubMed    


    April 2023
  102. HUNTER LD, Doubell AF, Pecoraro AJK, Monaghan M, et al
    Morpho-mechanistic screening criteria for the echocardiographic detection of rheumatic heart disease.
    Heart. 2023 Apr 28:heartjnl-2022-322192. doi: 10.1136/heartjnl-2022-322192.
    PubMed     Abstract available


  103. OTTO CM
    Heartbeat: sudden cardiac death risk in patients with hypertrophic cardiomyopathy.
    Heart. 2023;109:725-727.
    PubMed    


  104. RUBIS P
    Low-normal systolic function and hypertrophic cardiomyopathy.
    Heart. 2023;109:732-733.
    PubMed    


  105. CHOI YJ, Kim HK, Hwang IC, Park CS, et al
    Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
    Heart. 2023;109:771-778.
    PubMed     Abstract available


  106. CRAMARIUC D, Urheim S
    Pulmonary hypertension in significant aortic valve disease: a dive into real-world data.
    Heart. 2023 Apr 24:heartjnl-2023-322495. doi: 10.1136/heartjnl-2023-322495.
    PubMed    


  107. RATWATTE S, Playford D, Stewart S, Strange G, et al
    Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes.
    Heart. 2023 Apr 3:heartjnl-2022-322187. doi: 10.1136/heartjnl-2022-322187.
    PubMed     Abstract available


  108. RATWATTE S, Stewart S, Strange G, Playford D, et al
    Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes.
    Heart. 2023 Apr 3:heartjnl-2022-322184. doi: 10.1136/heartjnl-2022-322184.
    PubMed     Abstract available


    March 2023
  109. PAUSCH J, Harmel E, Reichenspurner H, Kempfert J, et al
    Subannular repair in secondary mitral regurgitation with restricted leaflet motion during systole.
    Heart. 2023 Mar 27:heartjnl-2022-322239. doi: 10.1136/heartjnl-2022-322239.
    PubMed     Abstract available


  110. OTTO CM
    Heartbeat: heart valve clinics improve outcomes in patients with aortic valve stenosis.
    Heart. 2023;109:573-575.
    PubMed    


  111. BISWAS A, Shukla A, Kothari SS
    Typical effort angina in a tall adult.
    Heart. 2023;109:605-650.
    PubMed    


  112. GARTSHTEYN Y, Bhave N, Joseph MS, Askanase A, et al
    Inflammatory and thrombotic valvulopathies in autoimmune disease.
    Heart. 2023;109:583-588.
    PubMed     Abstract available


  113. MARON MS, Rowin E, Spirito P, Maron BJ, et al
    Differing strategies for sudden death prevention in hypertrophic cardiomyopathy.
    Heart. 2023;109:589-594.
    PubMed     Abstract available


  114. VELDERS BJJ, Vriesendorp MD, De Lind Van Wijngaarden RAF, Rao V, et al
    Perioperative care differences of surgical aortic valve replacement between North America and Europe.
    Heart. 2023 Mar 24:heartjnl-2023-322350. doi: 10.1136/heartjnl-2023-322350.
    PubMed     Abstract available


  115. GEERS J, Bing R
    Computed tomographic imaging of patients with native and prosthetic aortic valve stenosis.
    Heart. 2023 Mar 22:heartjnl-2022-321660. doi: 10.1136/heartjnl-2022-321660.
    PubMed    


  116. BEYER SE, Secemsky EA, Khabbaz K, Carroll BJ, et al
    Elective ascending aortic aneurysm repair outcomes in a nationwide US cohort.
    Heart. 2023 Mar 16:heartjnl-2022-322033. doi: 10.1136/heartjnl-2022-322033.
    PubMed     Abstract available


  117. ALI Z, Flynn AW
    Severe aortic stenosis and the need for the right treatment, in the right place, at the right time.
    Heart. 2023 Mar 13:heartjnl-2022-322195. doi: 10.1136/heartjnl-2022-322195.
    PubMed    


  118. OTTO CM
    Heartbeat: clinical practice patterns for valve intervention in adults with aortic stenosis.
    Heart. 2023;109:495-497.
    PubMed    


    February 2023
  119. KRIEGER EV, Burke CR, McCabe JM
    Sometimes mechanical, never routine: aortic valve replacement in young adults.
    Heart. 2023 Feb 27:heartjnl-2022-322150. doi: 10.1136/heartjnl-2022-322150.
    PubMed    


  120. STOICA S, Beard C, Takkenberg JJM, Mokhles MM, et al
    Formal consensus study on surgery to replace the aortic valve in adults aged 18-60 years.
    Heart. 2023 Feb 27:heartjnl-2022-321740. doi: 10.1136/heartjnl-2022-321740.
    PubMed     Abstract available


  121. DREYFUS J, Bohbot Y, Coisne A, Lavie-Badie Y, et al
    Predictive value of the TRI-SCORE for in-hospital mortality after redo isolated tricuspid valve surgery.
    Heart. 2023 Feb 24:heartjnl-2022-322167. doi: 10.1136/heartjnl-2022-322167.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.